Plasma particle accelerators more powerful than existing machines could help probe some of the outstanding mysteries of our universe, as well as make leaps forward in cancer treatment and security scanning - all in a package that’s around a thousandth of the size of current accelerators. All that's left is for scientists to build one.
If you know what a particle accelerator is, you probably think first of the Large Hadron Collider (LHC) – that gargantuan ring on the Franco-Swiss border that smashes protons and ions together, exposing the secrets of the subatomic world.
Built by the European lab CERN, the LHC accelerates particles to the kinds of speeds found during the eruption of the early universe. To do so, it needs a very, very big circumference – 27 kilometres.
Yet the LHC is already finding limits to what it can explore. Physicists want even more powerful accelerators – but building one much bigger than the LHC is hard to contemplate.
Dr Ralph Assmann, a leading scientist at the German particle physics lab DESY, believes a completely different approach is needed. He thinks accelerators can be powerful, yet up to 1,000 times smaller, if they are based on a strange type of matter known as a plasma – a cloud of negative electrons and positive ions.
‘Plasma accelerators provide a path to energies beyond the LHC,’ he said. ‘Particle physicists must take this opportunity very seriously.’
Conventional accelerators work by sending charged particles through oscillating electromagnetic fields. By switching back and forth, these fields kick the particles to an incrementally higher energy with every cycle – a bit like pushing a child on a swing.
'Particle physicists must take this opportunity very seriously.'
Dr Ralph Assmann, Leading Scientist, DESY
The trouble with this approach is that the individual kicks – which are generated by electrical components – can only be so powerful, or the field itself will break down. High energies therefore demand lots and lots of soft kicks, which is why conventional accelerators get so big.
Plasmas, however, can sustain much bigger fields. Nearly 40 years ago, physicists discovered that if a laser pulse or a particle beam is sent into a plasma, it is possible to momentarily separate the negative and positive charges, generating a field of some 100 billion volts per metre.
Any electrons stranded in the wake of this separation are propelled forwards. The effect, like a surfer riding a wave, is known as plasma wakefield acceleration.
In recent years, the energies accessible with plasma wakefield accelerators have risen sharply. Scientists like Dr Assmann want to increase these energies, but also to improve the stability and quality of the electron beams coming out of the accelerator.
Host of applications
That would make plasma accelerators suitable for particle physics but also a host of other applications, including cancer treatment, medical diagnostics, security scanners and the study of advanced materials. Conventional accelerators already help with these applications, but their size and cost means that demand currently far outstrips supply.
Dr Assmann is coordinating a project, EuPRAXIA, to come up with a design for the world’s first plasma wakefield accelerator with an energy of five giga-electronvolts (GeV) that can actually be used for research. That is less than one-thousandth the energy of the LHC but, as Dr Assmann points out, you have to walk before you can run.
‘Clearly, high-field accelerators, like plasma accelerators, (are) the logical long-term solution for advancing the energy frontier in particle physics,’ he said. ‘But it will require a realistic and sustained approach.’
With 40 labs and universities on board, EuPRAXIA will have to answer key questions, such as whether all the accelerated electrons should come from the plasma, or whether additional electrons should be fed into the machine. The design is expected to be completed towards the end of next year.
EuPRAXIA is not the only plasma accelerator project in town, however. At CERN, a powerful wakefield accelerator called AWAKE has already been built, but with a twist – it uses a proton beam to drive it.
Protons are more than 1,800 times more massive than electrons, which means they have a much bigger impact when it comes to dividing the charges in a plasma. According to Dr Edda Gschwendtner, the CERN project leader of the AWAKE experiment, that means a proton-driven plasma accelerator could accelerate electrons to high energies in just a single stage, rather than multiple stages, as is often proposed.
AWAKE takes the proton beam from one of CERN’s existing accelerators, and in the last two years has successfully created strong plasma wakefields. This year, the goal is to actually accelerate electrons in that wakefield to energies exceeding 1 GeV.
In years to come, Dr Gschwendtner wants to boost AWAKE’s output to several tens of GeV. That would be enough to probe certain theoretical proposals of today’s particle physics – dark photons, for instance, which some physicists believe could constitute the dark matter that predominates in the universe.
Plasma accelerators still have a long way to go before they can out-perform the likes of the LHC. But when conventional accelerators are so big and costly, Dr Gschwendtner believes they could be the only way forward.
‘New technologies must be developed,’ she said. ‘Plasma wakefield acceleration is a very promising novel accelerator technique.’
The research in this article has received EU funding. If you liked this article, please consider sharing it on social media.
Developing new propellants for satellites to replace toxic hydrazine would make launching and handling satellites safer but it also requires disrupting current systems, according to researchers.
We know that outbreaks like coronavirus will become more common in the future and tackling them is the Apollo programme of our time, according to Professor Marion Koopmans, head of the viroscience department at Erasmus University Medical Centre in Rotterdam, the Netherlands.
The race for a vaccine against the novel coronavirus, or SARS-CoV-2, is on, with 54 different vaccines under development, two of which are already being tested in humans, according to the World Health Organization. And among the different candidates is a new player on the scene – mRNA vaccines.
Metagenomics can help us spot emerging diseases, says virologist Marion Koopmans.
What are they and why are they promising for coronavirus?
The more satellite launches we do, the bigger the risk of damage or debris, says Dimitra Stefoudi.